These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 13278832)

  • 1. Antituberculosis agents. I. Bisdialkylaminoalkyl sulphones and related substances.
    EDWARDS D; STENLAKE JB
    J Pharm Pharmacol; 1955 Nov; 7(11):852-61. PubMed ID: 13278832
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimycobacterial activity of some quinolyl aryl sulfides, sulfones, and ethers, in vitro.
    Akerkar AS; Naftchi NE
    Antimicrob Agents Chemother; 1972 May; 1(5):392-6. PubMed ID: 4207953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative data from an experimental-clinical study of new antituberculosis drugs].
    Utkin VV
    Antibiotiki; 1972 Sep; 17(9):851-6. PubMed ID: 4631726
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyttoxic and cancerostatic activity of isothiocyanates and related compounds. V. ITC with sulphide and sulphone groups.
    Horáková K; Drobnica L; Nemec P; Uher M
    Neoplasma; 1970; 17(1):3-8. PubMed ID: 4986664
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bacteriological substantiation of the antituberculosis effect of immunotropic drug tubosan].
    Kibrik BS; Pavlov AV; Chelnokova OG
    Eksp Klin Farmakol; 2013; 76(2):20-2. PubMed ID: 23631279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of causative agents of tuberculosis with xanthogenates].
    IVANOV ID; TODOROV T
    Izv Mikrobiol Inst (Sofiia); 1956; 7():97-101. PubMed ID: 13385073
    [No Abstract]   [Full Text] [Related]  

  • 7. A new class of antituberculosis agents.
    Jones PB; Parrish NM; Houston TA; Stapon A; Bansal NP; Dick JD; Townsend CA
    J Med Chem; 2000 Aug; 43(17):3304-14. PubMed ID: 10966749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action of protionamide on tuberculosis mycobacteria in vitro].
    Kalabukha AV; Klimenko MT
    Mikrobiol Zh; 1972; 34(6):778-82. PubMed ID: 4199956
    [No Abstract]   [Full Text] [Related]  

  • 9. [The activity of several compounds from the arylamide, azomethine and oxine groups against M. tuberculosis in vitro].
    Rotmistrov MM; Drabkina RI; Kulik HV; Skrynik IeM; Gorbonos TV
    Mikrobiol Zh; 1970; 32(3):374-6. PubMed ID: 4996137
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitubercular agent formed by condensing bis (4-aminophenyl)-sulfone with 1-ascorbic acid.
    KUMLER WD; SAH PP
    J Am Pharm Assoc Am Pharm Assoc; 1952 Aug; 41(8):445-50. PubMed ID: 12990517
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental study on the antitubercular activity of butomelide].
    Pershin GN; Zykova TN
    Probl Tuberk; 1972; 50(7):60-3. PubMed ID: 4626206
    [No Abstract]   [Full Text] [Related]  

  • 12. Pyrazole derivatives from azines of substituted phenacyl aryl/cyclohexyl sulfides and their antimycobacterial activity.
    Manikannan R; Venkatesan R; Muthusubramanian S; Yogeeswari P; Sriram D
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6920-4. PubMed ID: 20970331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A heterocyclic-substituted sulfone with activity against Mycobacterium tuberculosis.
    VOGEL RH; KOPAC MJ
    Proc Soc Exp Biol Med; 1951 Aug; 77(4):859-60. PubMed ID: 14891894
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antitubercular activity of benzisothiazoline-3-thione and of 3-imino-benzo-1,2-dithiol].
    Ambrosoli G; Ciuti MP; Menozzi MG; Mingiardi MR
    Boll Chim Farm; 1970 Apr; 109(4):251-8. PubMed ID: 5002476
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on streptomycin resistance in strains of Mycobacterium tuberculosis cultured from saliva of patients treated with streptomycin].
    KOLSUT H
    Gruzlica (1926); 1951; 19(5):577-84. PubMed ID: 14887981
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rational chemotherapy of tuberculosis, antituberculosis activity of bis (2,3-dihydroxypro-poxyethyl)-amine and its N-alkyl derivatives].
    GRUNDLAND I; RUMPF P; GALLAND R; CABAU N; SADET J
    Experientia; 1953 Aug; 9(8):313-6. PubMed ID: 13095440
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary drug resistance of Mycobacterium tuberculosis to antituberculosis drugs.
    Safi MI; Zai S
    J Pak Med Assoc; 1988 Mar; 38(3):73-4. PubMed ID: 3133501
    [No Abstract]   [Full Text] [Related]  

  • 18. [Resistance to antitubercular drugs in patients with tuberculosis registered in the antituberculosis clinics in Poland 1966-1980].
    Szczuka I
    Pneumonol Pol; 1982 Oct; 50(10):497-501. PubMed ID: 6820494
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relationship between the structure and antibacterial activity of aryl-thioamides. V. Synthesis and in vitro tuberculostatic activity of 2-alkylthio-benzothiamides and 2-alkylthio-phenyl-vinylethionamides].
    Tornetta B; Guerrera F; Mazzarino C
    Boll Chim Farm; 1973 Dec; 112(12):822-31. PubMed ID: 4210251
    [No Abstract]   [Full Text] [Related]  

  • 20. [A comparative study of the susceptibilities to antituberculosis agents between Mycobacterium tuberculosis and Mycobacterium avium complex strains].
    Tsukamura M
    Kekkaku; 1987 Jun; 62(6):345-8. PubMed ID: 3116312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.